Pall/Ciphergen Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Pall buys Ciphergen's BioSepra Process Division for $32 mil., net of cash and debt. The purchase adds chromatography sorbents "that greatly simplify protein purification development and significantly improve biopharmaceutical manufacturing productivity," Pall says. Ciphergen notes that the divestiture will allow it to focus on its diagnostics and biosystems units...